General Information of This Antigen
Antigen ID
TAR0DQWRU
Antigen Name
C-X-C chemokine receptor type 4 (CXCR4)
Gene Name
CXCR4
Gene ID
7852
Synonym
FB22;Fusin;HM89;LCR1;Leukocyte-derived seven transmembrane domain receptor;Lipopolysaccharide-associated protein 3;NPYRL;Stromal cell-derived factor 1 receptor;CD_antigen=CD184
Sequence
MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVI
LVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNL
YSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEA
DDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKT
TVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPI
LYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS

    Click to Show/Hide
Family
G-protein coupled receptor 1 family
Function
Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ion levels and enhancing MAPK1/MAPK3 activation. Involved in the AKT signaling cascade. Plays a role in regulation of cell migration, e.g. during wound healing. Acts as a receptor for extracellular ubiquitin; leading to enhanced intracellular calcium ions and reduced cellular cAMP levels. Binds bacterial lipopolysaccharide (LPS) et mediates LPS-induced inflammatory response, including TNF secretion by monocytes. Involved in hematopoiesis and in cardiac ventricular septum formation. Also plays an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. Involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival.

    Click to Show/Hide
Uniprot Entry
CXCR4_HUMAN
HGNC ID
HGNC:2561
KEGG ID
hsa:7852
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
12A11-TG6
ADC Name Payload Target Linker ADC Info
12A11-TG6-vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
3G10-TG6-vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
3G10-TG6-vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
6B6-TG6-vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
6B6-TG6-vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-CXCR4 mAb h17-NA
ADC Name Payload Target Linker ADC Info
Anti-CXCR4 ADC 553 [2]
Auristatin 0101
Microtubule (MT)
AcLys-Val-Cit-PABC
Anti-CXCR4 ADC 671 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 ADC 711 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 ADC 712 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 mAb h17-NQ
ADC Name Payload Target Linker ADC Info
Anti-CXCR4 ADC 555 [2]
Auristatin 0101
Microtubule (MT)
AcLys-Val-Cit-PABC
Anti-CXCR4 ADC 669 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 mAb h17-NS
ADC Name Payload Target Linker ADC Info
Anti-CXCR4 ADC 554 [2]
Auristatin 0101
Microtubule (MT)
AcLys-Val-Cit-PABC
Anti-CXCR4 ADC 672 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 mAb h17-NV.TS
ADC Name Payload Target Linker ADC Info
Anti-CXCR4 ADC 556 [2]
Auristatin 0101
Microtubule (MT)
AcLys-Val-Cit-PABC
Anti-CXCR4 ADC 670 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 ADC 713 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 ADC 714 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 mAb m17
ADC Name Payload Target Linker ADC Info
Anti-CXCR4 ADC 513 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 ADC 518 [2]
Auristatin 0101
Microtubule (MT)
AcLys-Val-Cit-PABC
Anti-CXCR4 ADC 510 [2]
Aur0131
Microtubule (MT)
AmPEG6C2
Anti-CXCR4 ADC 519 [2]
Auristatin 0101
Microtubule (MT)
AcLys-Val-Cit-PABC
Anti-CXCR4 ADC 381 [2]
Auristatin 0101
Microtubule (MT)
AcLys-Val-Cit-PABC
h3G10.1.91-h3G10.2.72
ADC Name Payload Target Linker ADC Info
h3G10.1.91-h3G10.2.72 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.1.91-h3G10.2.72 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.1.91-h3G10.A58
ADC Name Payload Target Linker ADC Info
H3G10.1.91-h3G10.A58 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.1.91-h3G10.A58 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.1.91-h3G10.A58 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.1.91-h3G10.A58 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.2.37-h3G10.2.72
ADC Name Payload Target Linker ADC Info
h3G10.2.37-h3G10.2.72 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.2.37-h3G10.2.72 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.2.37-h3G10.A58
ADC Name Payload Target Linker ADC Info
H3G10.2.37-h3G10.A58 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.2.37-h3G10.A58 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.2.37-h3G10.A58 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.2.37-h3G10.A58 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.A57-h3G10
ADC Name Payload Target Linker ADC Info
h3G10.A57-h3G10 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.A57-h3G10 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.A57-h3G10.2.72
ADC Name Payload Target Linker ADC Info
h3G10.A57-h3G10.2.72 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.A57-h3G10.2.72 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
h3G10.A57-h3G10.A58
ADC Name Payload Target Linker ADC Info
H3G10.A57-h3G10.A58 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.A57-h3G10.A58 vc0101 [1]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.A57-h3G10.A58 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
H3G10.A57-h3G10.A58 vcMMAD [1]
Monomethyl auristatin D
Microtubule (MT)
Mc-Val-Cit-PABC
Undisclosed
ADC Name Payload Target Linker ADC Info
HLCX-SS-dasatinib ADC [3]
Dasatinib
Breakpoint cluster region protein (BCR)
Dasatinib disulfide cleavable linker
CD184-tacrolimus antibody drug conjugate [4]
Tacrolimus
Peptidyl-prolyl cis-trans isomerase FKBP1A (FKBP1A)
Undisclosed
References
Ref 1 Anti-cxcr4 antibodies and antibody-drug conjugates.
Ref 2 Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates. Sci Rep. 2019 Feb 21;9(1):2443. doi: 10.1038/s41598-019-38745-x.
Ref 3 An immunosuppressive antibody-drug conjugate. J Am Chem Soc. 2015 Mar 11;137(9):3229-32. doi: 10.1021/jacs.5b00620. Epub 2015 Feb 27.
Ref 4 Ambrx biopharmaceutical company overview; 2014